Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Return on Invested Capital (2018 - 2021)

Acro Biomedical (ACBM) has 4 years of Return on Invested Capital data on record, last reported at 6.27% in Q3 2021.

  • For Q3 2021, Return on Invested Capital changed N/A year-over-year to 6.27%; the TTM value through Sep 2021 reached 6.27%, changed N/A, while the annual FY2020 figure was 0.13%, N/A changed from the prior year.
  • Return on Invested Capital reached 6.27% in Q3 2021 per ACBM's latest filing, down from 1.25% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.37% in Q3 2018 and bottomed at 6.27% in Q3 2021.
  • Average Return on Invested Capital over 4 years is 0.6%, with a median of 0.17% recorded in 2019.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 46bps in 2020, then tumbled -100bps in 2021.
  • A 4-year view of Return on Invested Capital shows it stood at 0.21% in 2018, then crashed by -378bps to 0.58% in 2019, then surged by 79bps to 0.12% in 2020, then crashed by -5065bps to 6.27% in 2021.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 6.27% in Q3 2021, 1.25% in Q2 2021, and 0.28% in Q1 2021.